Growth Equity
European Equity
European Equity takes minority stakes in growing companies, usually without full control, from London, United Kingdom. It states a focus on healthcare & life sciences.
SEC filings
What European Equity has raised
From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.
| Vehicles filed | 1 |
| Total capital raised | $66m |
| Largest single vehicle | $66m |
| Filing history | 2016 |
| Smallest accepted commitment | None stated |
| Filed from | CONNECTICUT |
Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.
Portfolio
Disclosed holdings
Companies European Equity lists on its own website. 5 carry a stated investment year.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| Bio-Research | 1992 | 34 | — |
| Aster-Cephac | 1996 | 30 | — |
| CMC Biologics | 2002 | 24 | — |
| Azanta | 2015 | 11 | — |
| Bactolife | 2017 | 9 | — |
| Abc | — | — | — |
| Agcbio | — | — | — |
| Basinc | — | — | — |
| Criver | — | — | — |
| INVESTORS IN THE EEP FUNDS | — | — | — |
| Infinera | — | — | — |
| PharmaKinetics | — | — | — |
| Sgs | — | — | — |
| Verdot | — | — | — |
| Verdot Biotechnologies | — | — | — |
Compiled from European Equity’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this European Equity?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other growth equity investors active in healthcare & life sciences.